On episode #76 of the Infectious Disease Puscast, Daniel and Sara review the infectious disease literature for the weeks of 2/27/25 – 3/12/25.
Hosts: Daniel Griffin and Sara Dong Subscribe (free): Apple Podcasts, RSS, email
Become a patron of Puscast!
Links for this episode * Viral * Trends in respiratory pathogen testing at us children’s hospitals (JAMA Network) * Changes in respiratory viral testing before and after the covid-19 pandemic(JAMA Network) * Expanding measles outbreak in the United States and guidance for the upcoming travel season (CDC Emergerncy Preparedness and Response) * Measles cases and outbreaks (CDC Measles (Rubeola)) * Facts and myths about measles (LANCET: Infectious Diseases) * Protective effects of recombinant zoster vaccine and antiviral therapy against cardiovascular disease following herpes zoster infection (JID) * Chikungunya vaccine information for healthcare providers (CDC Chikungunya Virus) * Factors to assess when considering use of chikungunya vaccine(CDC) * Bacterial * Should patients hospitalized forcommunity-acquired pneumonia be treated with additional antimicrobial agents directed against anaerobes? (American Journal of Therapeutics) * Antibiotic-induced loss of gut microbiome metabolic output correlates with clinical responses to CAR T-cell therapy(Blood) * Effectiveness of ampicillin/sulbactam versus ceftriaxone for the initial treatment of community-acquired pneumonia in older adults: a target trial emulation study(OFID) * Male-partner treatment to prevent recurrence of bacterial vaginosis(NEJM) * Fungal * The Last of US Season 2 (YouTube) * Activity of rezafungin against echinocandin non–wild type candida glabrata clinical isolates from a global surveillance program (OFID) * Are contemporary antifungal doses sufficient for critically ill patients? Outcomes from an international, multicenter pharmacokinetics study for Screening Antifungal Exposure in Intensive Care Units—the SAFE-ICU study (Intensive Care Medicine) * Parasitic * Human alveolar echinococcosis – global, regional and national annual incidence and prevalence rates (CMI: Clinical Microbiology and Infection) * Dust to Diagnosis – with MSGERC (FEBRILE) * The clinical picture caused by Fasciola gigantica: Analysis of 3,250 patients along the 1995–2019 countrywide spread in Vietnam (OFID) * Miscellaneous * Reprint of: From medical editors: a call to the global infectious diseases and clinical microbiology community (CMI: Clinical Microbiology and Infection) * A hot topic: A climate-focused track for infectious disease fellowship (OFID) * Are we being gaslit? A primer for recognizing corporate jargon to overcome gaslighting for the infectious disease workforce (CID)
Music is by Ronald Jenkees
Information on this podcast should not be considered as medical advice.